Kari Kuulasmaa

researcher

Kari Kuulasmaa is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID01255257303.12
P496ORCID iD0000-0003-2165-1411
P10861Springer Nature person ID01255257303.12
P1556zbMATH author IDkuulasmaa.kari

P108employerNational Institute for Health and WelfareQ4354957
P734family nameKuulasmaaQ42042220
KuulasmaaQ42042220
KuulasmaaQ42042220
P735given nameKariQ1333594
KariQ1333594
P6104maintained by WikiProjectWikiProject MathematicsQ8487137
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q26155907A century of trends in adult human height
Q24615584A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease
Q37568754A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Q49028473A multiple biomarker risk score for guiding clinical decisions using a decision curve approach
Q44932398A prospective study on reproducibility of the spread of spinal anesthesia using plain 0.5% bupivacaine
Q31007028Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985.
Q36008013Adiposity as a cause of cardiovascular disease: a Mendelian randomization study
Q47630236Adjusting for selective non-participation with re-contact data in the FINRISK 2012 survey
Q35532305Age- and sex-specific causal effects of adiposity on cardiovascular risk factors
Q38948539Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project.
Q114598667An agenda-setting paper on data sharing platforms: euCanSHare workshop
Q21146959An overview of the European Health Examination Survey Pilot Joint Action
Q58390864Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project
Q93047261Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
Q91764288Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
Q40963880Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA project.
Q98647222Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
Q91001741Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium
Q40391491Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
Q34340697BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
Q44236419Blood pressure levels in the 41 populations of the WHO MONICA Project
Q57303240Blood pressure profiles, and awareness and treatment of hypertension in Europe – results from the EHES Pilot Project
Q98564239Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project
Q36409742Case-cohort design in practice - experiences from the MORGAM Project
Q35494762Challenges in standardization of blood pressure measurement at the population level
Q38848824Changes in CVD Incidence and Mortality Rates, and Life Expectancy: North Karelia and National
Q45117545Changes in cancer incidence in North Karelia, an area with a comprehensive preventive cardiovascular programme
Q35564883Changes in cigarette smoking among adults in 35 populations in the mid-1980s. WHO MONICA Project
Q32053074Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases
Q39253446Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts
Q36851336Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Q47602938Cohort Profile: The National FINRISK Study
Q35559474Cold periods and coronary events: an analysis of populations worldwide
Q57259854Combined Effects of Thrombosis Pathway Gene Variants Predict Cardiovascular Events
Q96822365Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults
Q40478612Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: Implications for prevention.
Q33293167Combined effects of thrombosis pathway gene variants predict cardiovascular events
Q94463529Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
Q33195851Comparison of trends in ischaemic heart disease between North Karelia, Finland, and Kaunas, Lithuania, from 1971 to 1987.
Q58391002Confidence intervals for weighted sums of poisson parameters
Q48100250Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study
Q38416428Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project
Q101454035Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project
Q50647592Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.
Q58390904Coronary events and coronary care: MONICA project
Q58390909Coronary events and coronary care: MONICA project
Q42552278Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project
Q58390846Corrigendum to “Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly” [Atherosclerosis 178 (1) (2005) 129–138]
Q35539063Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations
Q45746988Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations
Q93632246Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations
Q34289735Decline in cardiovascular mortality in North Karelia and other parts of Finland
Q58391044Decline in cardiovascular mortality in North Karelia and other parts of Finland
Q47730052Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study
Q44299087Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study
Q98778223Decomposing the educational gradient in allostatic load across European populations. What matters the most: differentials in exposure or in susceptibility?
Q51912693Defining thirds of schooling years in population studies.
Q47665220Determinants of social inequalities in stroke incidence across Europe: a collaborative analysis of 126 635 individuals from 48 cohort studies
Q58390982Diagnostic features of acute myocardial infarction - changes over time from 1983 to 1990: results from the FINMONICA AMI register study
Q41577671Differences in participation rates and lessons learned about recruitment of participants--the European Health Examination Survey Pilot Project
Q36903035Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?
Q39562801Do other cardiovascular risk factors influence the impact of age on the association between blood pressure and mortality? The MORGAM Project
Q44168383Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke Project. World Health Organization Monitoring of T
Q40927114Educational class inequalities in the incidence of coronary heart disease in Europe
Q36990041Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES)
Q52979023Effect of sampling frames on response rates in the WHO MONICA risk factor surveys.
Q90169533Estimating expected life-years and risk factor associations with mortality in Finland: cohort study
Q52043313Estimation of an errors-in-variables regression model when the variances of the measurement errors vary between the observations.
Q33854955Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
Q58390921Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations
Q34358420European Health Examination Survey--towards a sustainable monitoring system.
Q55513977European health examination surveys – a tool for collecting objective information about the health of the population.
Q52992571Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield.
Q45071322Exome-wide association study of plasma lipids in >300,000 individuals
Q36494494Factors influencing the outcome of laser trabeculoplasty
Q58390832Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study
Q21092169Gender differences in genetic risk profiles for cardiovascular disease
Q57661758Genetic evidence of assortative mating in humans
Q33768940Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles
Q34358091Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts
Q22305005Genetic studies of body mass index yield new insights for obesity biology
Q35948055Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium
Q28943288Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture
Q57315333Haplotypic analysis of tag SNPs of the interleukin-18 gene in relation to cardiovascular disease events: the MORGAM Project
Q31044366HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studie
Q39337183High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
Q90327360High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium
Q36788804Hospital discharge register data in the assessment of trends in acute myocardial infarction. FINMONICA AMI Register Study Team
Q34224453Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project
Q45355671Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project
Q28648234Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium
Q41247711Individual predictability of repeated spinal anaesthesia with isobaric bupivacaine
Q36637803Ischemic stroke is associated with the ABO locus: the EuroCLOT study
Q33453963Lack of association between polymorphisms of the IL18R1 and IL18RAP genes and cardiovascular risk: the MORGAM Project
Q35859799Large scale association analysis of novel genetic loci for coronary artery disease
Q36921066Large-scale association analysis identifies new risk loci for coronary artery disease
Q38690186Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
Q58391066Locally Dependent Random Graphs and their use in the Study of Epidemic Models
Q43757364Long-term prognosis after coronary artery bypass surgery
Q57178033Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women - results from the FINRISK study
Q35961881MORGAM (an international pooling of cardiovascular cohorts).
Q57605696Measures of Abdominal Adiposity and the Risk of Stroke
Q63352621Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci
Q51617926Methods of total cholesterol measurement in the baseline survey of the WHO MONICA Project.
Q40412681Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients
Q50971500Mild myocardial infarction--a classification problem in epidemiologic studies. WHO MONICA Project.
Q48455677Modelling the burden of stroke in Finland until 2030.
Q58390959Multinational Comparison of Diagnostic Procedures and Management of Acute Stroke: The WHO MONICA Study
Q52880881Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA Stroke Study. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease.
Q50119393Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Q58390827Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study
Q45177991Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly
Q91755242NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke
Q35114362New genetic loci link adipose and insulin biology to body fat distribution
Q58391080On spàtial general epidemics and bond percolation processes
Q58391094On the reproduction rate of the spatial general epidemic
Q57315735PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION
Q34452559Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication.
Q44660879Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease
Q55149583Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Q92241818Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women - evidence from the FINRISK97 study
Q36376682Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
Q47177885Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Q62839973Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution
Q92503516Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Q51762287Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Q51779676Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Q58391014Quality assessment of blood pressure measurements in epidemiological surveys. The impact of last digit preference and the proportions of identical duplicate measurements. WHO Monica Project [corrected]
Q28656219Quality control and conduct of genome-wide association meta-analyses
Q31068432Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
Q29147547Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Q57303741Refining The Accuracy Of Validated Target Identification Through Coding Variant Fine-Mapping In Type 2 Diabetes
Q52327404Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
Q35405612Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study
Q50611525Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example.
Q58390914Relationship of Socioeconomic Status to the Incidence and Prehospital, 28-Day, and 1-Year Mortality Rates of Acute Coronary Events in the FINMONICA Myocardial Infarction Register Study
Q44389547Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project
Q34598124Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies
Q39927524Selection bias was reduced by recontacting nonparticipants.
Q47644063Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
Q92018809Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium
Q34765317Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits
Q41572885Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium
Q33704307Smoking and relative body weight: an international perspective from the WHO MONICA Project.
Q48820988Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register
Q57141510Standardisation of laboratories engaged in lipid analyses of population health examination surveys
Q36155184Standardization of total cholesterol measurement in population surveys--pre-analytic sources of variation and their effect on the prevalence of hypercholesterolaemia.
Q58390976Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project
Q44912002Stroke incidence and case fatality in Finland and in Akita, Japan: a comparative study
Q50946088Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations.
Q39827596Stroke risk estimation across nine European countries in the MORGAM project.
Q38505244Stroke trends in the WHO MONICA project
Q58390930Survival trends, coronary event rates, and the MONICA project
Q91330550Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
Q51034138Ten-year trends in stroke incidence and mortality in the FINMONICA Stroke Study.
Q57168399Testosterone Levels and Type 2 Diabetes-No Correlation with Age, Differential Predictive Value in Men and Women
Q30878015The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project--design, population and data harmonization of a large-scale, international study
Q51090110The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component.
Q58390816The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study
Q57157775The effect of temperature on systolic blood pressure
Q51598780The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity.
Q37297746The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals
Q37226746The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts
Q58391074The product representation of a locally dependent random graph
Q57605691The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project
Q28681102The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis
Q58391087The spatial general epidemic and locally dependent random graphs
Q36876575The validity of hospital discharge register data on coronary heart disease in Finland
Q33213147The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease
Q28752614Thirty-one novel biomarkers as predictors for clinically incident diabetes
Q35418823Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women
Q37324554Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension
Q38636258Transcriptome-Wide Analysis Identifies Novel Associations With Blood Pressure
Q26749640Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
Q58390894Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project
Q44161234Trends in coronary events in Finland during 1983-1997. The FINAMI study
Q43835727Trends in coronary risk factors in the WHO MONICA project.
Q58390870Trends in obesity and energy supply in the WHO MONICA Project
Q58390992Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988
Q51820914Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project.
Q37170644Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
Q30829589Under-estimation of obesity, hypertension and high cholesterol by self-reported data: comparison of self-reported information and objective measures from health examination surveys
Q58390875Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project
Q57315334Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts
Q58390928Varying Sensitivity of Waist Action Levels to Identify Subjects with Overweight or Obesity in 19 Populations of The WHO MONICA Project
Q38848832WHO MONICA Project and its Connections to the North Karelia Project.
Q36469198WHO MONICA Project: geographic variation in mortality from cardiovascular diseases. Baseline data on selected population characteristics and cardiovascular mortality
Q58390934Waist and hip circumferences and waist-hip ratio in 19 populations of the WHO MONICA Project
Q34624212World Health Organization definition of myocardial infarction: 2008-09 revision
Q109309676Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Q58390925[Usual risk factors and treatment explain the international differences in the coronary artery disease epidemic]

Search more.